| Title: | Metabolism syndrome and risk of cancer |
| Lead Institution: | Sun Yat-Sen University |
| Principal investigator: | Dr Jin-Qiu Yuan |
Application 51671
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
About
The metabolic syndrome (MetS) is a cluster of the most dangerous heart attack risk factors: diabetes and prediabetes, abdominal obesity, high cholesterol and high blood pressure. It affects around 20-25 percent of adults in the world. Previous studies have observed associations between MetS and cancer development and cancer-related deaths. However, it's still unclear which MetS components are more harmful, and whether the harmful effect are additive. For MetS and risk of certain site-specific cancer, the current evidence is still unclear. We therefore proposed this study to comprehensively evaluate MetS and cancer. We have three aims: 1. To investigate the MetS and subsequent overall and site-specific cancer risk/death 2. To investigate individual components of MetS and cancer risk/death 3. To investigate the interaction of individual components of MetS, in relation with cancer risk/ death This is a 2-year project. We will carry out a comprehensive analysis of MetS and cancer risk. The results will provide robust evidence for the management of MetS as well as the development of cancer prevention strategies.2 Returns
| Return ID | App ID | Description | Archive Date |
|---|---|---|---|
| 3265 | 51671 | Metabolic syndrome and risk of pancreatic cancer: A population-based prospective cohort study | 31 Mar 2021 |
| 3266 | 51671 | Serum uric acid levels and risk of kidney cancer incidence and mortality: A prospective cohort study | 31 Mar 2021 |
21 Publications
Enabling scientific discoveries that improve human health